These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12749406)

  • 1. Kinetics of degradation of quinapril hydrochloride in tablets.
    Stanisz B
    Pharmazie; 2003 Apr; 58(4):249-51. PubMed ID: 12749406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of degradation of enalapril maleate in dosage forms.
    Stanisz B
    Acta Pol Pharm; 2004; 61(6):415-8. PubMed ID: 15794332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of degradation of imidapril hydrochloride in finished dosage formulations.
    Stanisz B; Regulska K
    Acta Pol Pharm; 2013; 70(4):737-42. PubMed ID: 23923397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of diltiazem hydrochloride in solid phase.
    Muszalska I; Siakowski M
    Acta Pol Pharm; 2003; 60(1):27-30. PubMed ID: 12848364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of ceftazidime pentahydrate in medicinal preparations Biotum and Ceftim.
    Zajac M; Jelińska A; Sobczak A; Musiał W
    Acta Pol Pharm; 2005; 62(1):11-5. PubMed ID: 16022488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of pharmaceutical excipients on quinapril hydrochloride stability.
    Stanisz B
    Acta Pol Pharm; 2005; 62(3):189-93. PubMed ID: 16193811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a citrate buffer system on the solid-state chemical stability of lyophilized quinapril preparations.
    Li J; Guo Y; Zografi G
    Pharm Res; 2002 Jan; 19(1):20-6. PubMed ID: 11837696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of the crystalline form of cefaclor monohydrate and its pharmaceutical preparations.
    Medenecka B; Jelińska A; Zajac M; Bałdyka M; Juszkiewicz K; Oszczapowicz I
    Acta Pol Pharm; 2009; 66(5):563-9. PubMed ID: 19894653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of humidity and hydroxypropyl cellulose, hydroxypropylmethyl cellulose, glyceryl behenate or magnesium stearate on the degradation kinetics of quinapril hydrochloride in solid phase.
    Stanisz B; Paszun S; Strzyzycka N; Ptaszyński E
    Acta Pol Pharm; 2010; 67(1):99-102. PubMed ID: 20210086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of microcalorimetry and HPLC for the determination of degradation kinetics and thermodynamic parameters of Perindopril Erbumine in aqueous solutions.
    Simoncic Z; Roskar R; Gartner A; Kogej K; Kmetec V
    Int J Pharm; 2008 May; 356(1-2):200-5. PubMed ID: 18304767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrochemical behavior of quinapril and its determination in pharmaceutical formulations by square-wave voltammetry at a mercury electrode.
    Süslü I; Altinöz S
    Pharmazie; 2008 Jun; 63(6):428-33. PubMed ID: 18604985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations.
    Stanisz B; Regulska K; Kania J; Garbacki P
    Drug Dev Ind Pharm; 2013 Jan; 39(1):51-61. PubMed ID: 22348774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lyophilization on the physical characteristics and chemical stability of amorphous quinapril hydrochloride.
    Guo Y; Byrn SR; Zografi G
    Pharm Res; 2000 Aug; 17(8):930-5. PubMed ID: 11028937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stability of quinapril hydrochloride--a mixture of amorphous and crystalline forms (QHCl-AC)--in solid phase.
    Stanisz B
    Acta Pol Pharm; 2003; 60(6):443-9. PubMed ID: 15080591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of new potential ACE inhibitor in the aqueous solutions of different pH.
    Roskar R; Simoncic Z; Gartner A; Kmetec V
    J Pharm Biomed Anal; 2009 Feb; 49(2):295-303. PubMed ID: 19135817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of aztreonam in AZACTAM.
    Zajac M; Jelińska A; Cielecka-Piontek J; Oszczapowicz I
    Farmaco; 2005; 60(6-7):599-603. PubMed ID: 15932754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability and in vitro release profile of enalapril maleate from different commercially available tablets: possible therapeutic implications.
    Lima DM; dos Santos LD; Lima EM
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):934-7. PubMed ID: 18472382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical characteristics and chemical degradation of amorphous quinapril hydrochloride.
    Guo Y; Byrn SR; Zografi G
    J Pharm Sci; 2000 Jan; 89(1):128-43. PubMed ID: 10664545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydration and dehydration kinetics of xylazine hydrochloride.
    Bērziņs A; Actiņs A; Kreismanis JP
    Pharm Dev Technol; 2009; 14(4):388-99. PubMed ID: 19630697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilazapril stability in the presence of hydrochlorothiazide in model mixtures and fixed dose combination.
    Paszun SK; Stanisz BJ; Gradowska A
    Acta Pol Pharm; 2013; 70(6):1079-85. PubMed ID: 24383331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.